Digital 4th Annual Antifibrotic Drug Development Summit

Posted By : User Ref No: WURUR66611 0
  • Image
  • TypeConference
  • Image
  • Location United States
  • Price
  • Date 16-11-2020 - 18-11-2020
Digital 4th Annual Antifibrotic Drug Development Summit, United States
Conference Title
Digital 4th Annual Antifibrotic Drug Development Summit
Event Type
Conference
Conference Date
16-11-2020 to 18-11-2020
Location
United States
Organization Name / Organize By
Hanson Wade
Organizing/Related Departments
Hanson Wade
Organization Type
Organization/Company
ConferenceCategory
Non Technical
ConferenceLevel
All (State/Province/Region, National & International)
Related Industries

Medical/Healthcare/Hospital

Location
United States

Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic understanding of fibrosis into clinically effective therapeutics across disease areas. With 3 days of in-depth cutting-edge case studies and the highest calibre of discussions from cross-disciplinary fibrosis heavy-weights, AFDD will bridge the current translational gap to anti-fibrotic drug development success 

Join 100+ fibrosis experts at this fully digital event to build a comprehensive network with like-minded peers and hurdle your translational drug development challenges to accelerate the development of more clinically effective drugs.  

URLs:
Brochure    https://go.evvnt.com/680187-4?pid=6581

Speakers: Andrew Billin Senior Director, Biomarker Sciences  Gilead, Bob Willette Senior Fibrosis Advisor  ImmunoMet, Cory Hogaboam Professor of Medicine and Adjunct Professor of Pathology  Cedars Sinai Medical Centre, Eric White Director Clinical Development and Medical Affairs – IPF/ILD  Boehringer Ingelheim, James Trevaskis Director, Fibrosis Biology, Research  Gilead, Jamie Bates Director, Fibrosis  Gilead, Jeremy Duffield Vice President  Vertex Pharmaceuticals, Johnathan Epstein William Wikoff Smith Professor, Executive Vice Dean and Chief Scientific Officer  Perelman School of Medicine at the University of Pennsylvania, Karim Christian El Kasmi Laboratory Head Immunology and Respiratory Macrophage Biology Innate Immunity  Boehringer Ingelheim, Ke Cheng Co-founder  BreStem Therapeutics, Kevin Fowler Principal  The Voice of the Patient, Rana Herro Assistant Professor  Cincinnati Children’s Hospital, Rob Slack Director of Pharmacology  Galecto, Rugmani Iyer Senior Scientist II  Merck, Samir Ounzain Chief Executive Officer and Scientific Co-Founder  HAYA Therapeutics, Scott MacDonnell Associate Director Cardiovascular, Fibrosis, and Renal Research  Regeneron Pharmaceuticals, Sunhwa Kim Principal Scientist  Merck, Wim van Schooten Chief Scientific Officer  TeneoBio

 

Others Details

Time: 8:30 am - 6:00 pm

Registration Fees
Available
Registration Fees Details
Conference Only: USD 2099.0, Full Access: USD 2948.0
Registration Ways
Website
Address/Venue
  Online 
Contact
Charlotte Harrison

[email protected]

   +1 4157353289